Australia’s first Green Biopharm

基于蛋白质的药物和疫苗是医药市场增长最快的部门，但由于传统制造系统的基础设施和运营成本高，澳大利亚中小型企业无法生产这些产品。该项目旨在开发先进的方法，利用本地植物生产蛋白质药物。这项技术的力量将通过生物抗寄生虫治疗来证明，作为过时的化学治疗的替代品。预期成果包括一项独特的可扩展技术，该技术将支持澳大利亚快速、经济、大规模生产高价值蛋白质的主权能力，而且复杂性低于目前的植物系统。

Protein-based medicines and vaccines represent the fastest growing sector of the pharmaceutical market, but their production by Australian small and medium enterprises is prohibited by the high infrastructure and operating costs of traditional manufacturing systems. This project aims to develop advanced methods to produce protein-based medicines using a native plant. The power of this technology will be demonstrated by making a biologic anti-parasite treatment, as an alternative to outdated chemical treatments. Expected outcomes include a unique scalable technology which will support Australia's sovereign capacity to produce high-value proteins, rapidly, affordably, and at scale, and with less complexity than current plant-based systems.